Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Neoplasms::Neoplasms by Site::Soft Tissue Neoplasms [DISEASES]"'
Autor:
Bonvalot, S., Rutkowski, P.L., Thariat, J., Carrere, S., Ducassou, A., Sunyach, M.P., Agoston, P., Hong, A.M., Mervoyer, A., Rastrelli, M., Moreno, V., Li, R.K., Tiangco, B.J., Herra, A.C., Gronchi, A., Sy-Ortin, T., Hohenberger, P., Baere, T. de, Cesne, A. le, Helfre, S., Saada-Bouzid, E., Anghel, R.M., Kantor, G., Montero, A., Loong, H.H., Verges, R., Kacso, G., Austen, L., Servois, V.F., Wardelmann, E., Dimitriu, M., Said, P., Lazar, A.J., Bovee, J.V.M.G., Pechoux, C. le, Papai, Z.
Publikováno v:
International Journal of Radiation Oncology-Biology-Physics, 114(3), 422-432. ELSEVIER SCIENCE INC
Scientia
Scientia
Calidad de vida; Sarcoma de tejido blando localmente avanzado; Radioterapia Qualitat de vida; Sarcoma de teixit tou localment avançat; Radioteràpia Quality of life; Locally advanced soft-tissue sarcoma; Radiation therapy Purpose Act.In.Sarc (NCT023
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::799a668896988c37a44d05460e9d5089
https://doi.org/10.1016/j.ijrobp.2022.07.001
https://doi.org/10.1016/j.ijrobp.2022.07.001
Autor:
Florent Guérin, Hélène Martelli, Timothy Rogers, Ilaria Zanetti, Sheila Terwisscha van Scheltinga, Federica De Corti, Gabriella Guillen Burrieza, Véronique Minard‐Colin, Daniel Orbach, Max M. van Noesel, Marie Karanian, Raquel Dávila Fajardo, Johannes H. M. Merks, Andrea Ferrari, Gianni Bisogno
Publikováno v:
Scientia
Liver; Pediatrics; Sarcoma Fetge; Pediatria; Sarcoma Hígado; Pediatría; Sarcoma Background To assess the outcomes of pediatric patients with undifferentiated embryonal sarcoma of the liver (UESL) and treatment including at least surgery and systemi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ebf7cd371b3cafacdb4a6d67acf9315
https://hdl.handle.net/11351/9836
https://hdl.handle.net/11351/9836
Publikováno v:
Scientia
BackgroundThe development of novel therapies for patients with sarcoma is challenging due to the rarity and diversity of these mesenchymal neoplasms. Hence, histology-agnostic approvals can be of particular interest for the treatment of patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e4a32058efa614ce98c0fa151ad8501
Autor:
Elena Arconada-Luque, Jaime Jiménez-Suarez, Raquel Pascual-Serra, Syong Hyun Nam-Cha, Teresa Moline, Francisco J. Cimas, Germán Fliquete, Marta Ortega-Muelas, Olga Roche, Diego M. Fernández-Aroca, Raúl Muñoz Velasco, Natalia García-Flores, Cristina Garnés-García, Adrián Sánchez-Fdez, Sofía Matilla-Almazán, Víctor J. Sánchez-Arévalo Lobo, Javier Hernández-Losa, Borja Belandia, Atanasio Pandiella, Azucena Esparís-Ogando, Santiago Ramón y Cajal, Luis del Peso, Ricardo Sánchez-Prieto, María José Ruiz-Hidalgo
Publikováno v:
Scientia
Cancers; Volume 14; Issue 14; Pages: 3509
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
instname
Cancers; Volume 14; Issue 14; Pages: 3509
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
instname
Artículo escrito por un elevado número de autores, solo se referencian el que aparece en primer lugar y los autores pertenecientes a la UAM
Sarcomas are a heterogeneous group of tumors in which the role of ERK5 is poorly studied. To clarify th
Sarcomas are a heterogeneous group of tumors in which the role of ERK5 is poorly studied. To clarify th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a35f38ed936ede7163f04b5c3022011
https://hdl.handle.net/10486/705994
https://hdl.handle.net/10486/705994
Autor:
Roberto Diaz-Beveridge, Luis Miguel De Sande-González, Antonio López Pousa, Jordi Rubió-Casadevall, Javier Martin-Broto, Pablo Luna, Juan Antonio Carrasco, Claudia M Valverde-Morales, Andres Poveda, Gloria Marquina, María Ángeles Vaz Salgado, Javier Martinez-Trufero, Antonio Gutierrez, Ana De Juan, Juana María Cano, Ibon Gurruchaga-Sotes, Isabel Sevilla, Josefina Cruz-Jurado, Jerónimo Martínez-García, Rosa Alvarez, David S. Moura
Publikováno v:
Cancers
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Cancers, Vol 13, Iss 792, p 792 (2021)
Scientia
Volume 13
Issue 4
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Cancers, Vol 13, Iss 792, p 792 (2021)
Scientia
Volume 13
Issue 4
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
The aim of this study was to identify an easily reliable prognostic score that selects the subset of advanced soft tissue sarcoma (ASTS) patients with a higher benefit with trabectedin in terms of time to progression and overall survival. A retrospec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7ae189020c1b9820dc01b3e6d0041c2
https://hdl.handle.net/10668/17307
https://hdl.handle.net/10668/17307
Autor:
Departament de Salut
Publikováno v:
Scientia
Olaratumab; Teixits tous; Tractament pal·liatiu Olaratumab; Soft tissues; Palliative treatment Olaratumab; Tejidos blandos; Tratamiento paliativo El tractament de primera línia per al sarcoma de parts toves (SPT) avançat en adults és la quimioter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3991::d7af12008c837bcca519fafb0454113e
https://hdl.handle.net/11351/3638
https://hdl.handle.net/11351/3638